Company
Veirulence Ltd
- Business model
- B2B
Record updated 28 September 2026
About
Veirulence Ltd is developing a first-in-class antibiotic-sparing treatment for P. aeruginosa infections aiming to change the standard-of-care for hospital-acquired bacterial infections.